2013/427/EU: Commission Implementing Decision of 2 August 2013 concerning a financial contribution by the Union to the emergency vaccination plan against classical swine fever in Latvia and Belarus and for the implementation of surveillance measures in Latvia, Lithuania and Belarus in the context of the emergency measures taken to combat this disease (notified under document C(2013) 4980)

1 In the context of the emergency measures taken to combat classical swine fever in 2013, Latvia shall be entitled to a specific contribution from the Union for the classical swine fever feral pigs emergency vaccination plan to be carried out in Latvia and in Belarus amounting to: (a) 100 % of the cost (not including VAT) of supply of the vaccine doses; (b) 50 % of the cost of salaries and fees paid to personnel carrying out the vaccinations in Latvia, and 50 % of the cost (not including VAT) of the expenditure directly associated with the vaccinations in Latvia.

2 The maximum amounts to be reimbursed to Latvia for the cost referred to in paragraph 1 shall not exceed: (a) for the purchase of vaccine, EUR 0,91 in average per dose; (b) for the vaccination, EUR 0,18 in average per vaccine dose distributed in Latvia; (c) EUR 130800 for vaccination cost in Latvia; (d) EUR 91000 for vaccination cost in Belarus.

1 In the context of the emergency measures taken to combat classical swine fever, Latvia and Lithuania shall be entitled to a financial contribution from the Union for the expenditure incurred for the costs of the laboratory tests for serological and virological surveillance measures in domestic and feral pigs carried out in Lithuania and in Belarus as from 1 April 2013 and in Latvia as from 20 November 2012.

2 The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by Latvia and Lithuania for the activities referred to in paragraph 1, and shall not exceed: (i) EUR 227000 for Latvia; (ii) EUR 17000 for Lithuania.

3 The maximum of the cost to be reimbursed to Latvia and Lithuania for the activities referred to in paragraph 1 shall in average not exceed: (i) EUR 0,5 per domestic pig sampled; (ii) EUR 5 per feral pig sampled; (iii) EUR 2 per ELISA test; (iv) EUR 10 per PCR test; (v) EUR 10 per virological test.

Subject to the results of any on-the-spot checks carried out in accordance with Article 11(1) of Decision 2009/470/EC, a first tranche payment shall be paid to Latvia as follows: (a) up to EUR 224300; (b) as part of the financial contribution from the Union provided for in Articles 1 and 2. That payment shall be made on the basis of an official request for reimbursement submitted by Latvia.

The expenditure eligible for a financial contribution by the Union for the measures referred to in Articles 1 and 2 shall be limited to the costs incurred by the Member States for the measures set out in points 1 to 4. 1. Sampling: (a) personnel, whatever the status, specifically allocated entirely or in part for carrying out the sampling; the costs are limited to actual salaries plus social security charges and other statutory costs included in the remuneration); and (b) overheads equal to 7 % of the sum of the cost referred to in (a). 2. Laboratory testing: (a) the purchase of test kits, reagents and all consumables identifiable and especially used for carrying out the laboratory tests; (b) personnel, whatever the status, specifically allocated entirely or in part for carrying out the tests in the premises of the laboratory; the costs are limited to actual salaries plus social security charges and other statutory costs included in the remuneration; and (c) overheads equal to 7 % of the sum of the costs referred to in (a) and (b). 3. The purchase and storage of vaccine doses and/or vaccine plus baits for wild animals. 4. The distribution of vaccines plus baits for wild animals: (a) personnel, whatever the status, specifically allocated entirely or in part for distributing vaccine baits; the costs are limited to their actual salaries plus social security charges and other statutory costs included in the remuneration; (b) overheads equal to 7 % of the sum of the costs referred to in (a).

1 The financial contribution from the Union as referred to in Articles 1 and 2 shall be paid on the basis of: (a) a final technical report in accordance with Annex I on the technical execution of the emergency vaccination, including the results attained during the period from 1 April 2013 to 31 December 2013; (b) a final technical report in accordance with Annex II on the technical execution of the surveillance measures, including the results attained during the period from 20 November 2012 in Latvia and from 1 April 2013 in Lithuania to 31 December 2013; (c) a final financial report, in computerised form in accordance with Annex III, on the costs incurred by Latvia during the period from 20 November 2012 to 31 December 2013 and by Lithuania during the period from 1 April 2013 to 31 December 2013; (d) the results of any on-the-spot checks carried out in accordance with Article 11(1) of Decision 2009/470/EC. The documents supporting the reports referred to in points (a) to (c) shall be made available for on-the-spot checks referred to in point (d) carried out by the Commission.

2 The final technical report and the final financial report referred to in paragraph 1(a) to 1(c) shall be submitted by 1 April 2014 at the latest. If that time limit is not observed, except if duly justified circumstances exist for this delay, the specific financial contribution from the Union shall be reduced by 25 % for every calendar month of delay.

This Decision is addressed to the Republic of Latvia and the Republic of Lithuania.